The American Journal of Managed Care11d
KIR2DS2+ NK Cells Show Potential in HCC and Leukemia Treatment
These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...
Nature7mon
Natural killer cells may broaden access to advanced cancer therapy
In 2010, a milestone was achieved when the first patient with cancer was treated with CAR-T-cell therapy. This pioneering treatment modifies a patient's T cells by inserting a gene for a chimeric ...
Yahoo Finance24d
First Patients Dosed in Phase 1 Clinical Study of ImmunityBio’s CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma
In the QUILT 106 trial, CD19-targeted high-affinity natural killer (t-haNK) cells are being tested initially ... in combination with the company’s IL-15 superagonist (N-803; ANKTIVA®) and ...
technologynetworks7mon
GMP Human 4-1BB Ligand Protein for T, NK, and DC Cell Culture
Conventionally, the first and second stimulation signals in vitro ... GMP Grade IL-2, IL-7, IL-15, IL-21, etc. 2. Enhance NK cell proliferation and cytotoxicity Studies have shown a significant ...